* Healthequity Inc HQY.OQ HQY.O is expected to show a
rise in
quarterly revenue when it reports results for the period
ending July 31 2023
* The Draper Utah-based company is expected to report a
12.7% increase in revenue to $243.609 million from $216.09
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data. (SAL majority is based on Total
Revenue)
* LSEG's mean analyst estimate for Healthequity Inc is for
earnings of 50 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 12 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Healthequity Inc
is $85.00, above its last closing price of $67.02.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jul. 31 2023 0.48 0.48 0.53 Beat 11
Apr. 30 2023 0.41 0.41 0.50 Beat 23.2
Jan. 31 2023 0.35 0.35 0.37 Beat 5.4
Oct. 31 2022 0.35 0.35 0.38 Beat 9.7
Jul. 0.33 0.33 0.33 Met 0
31 2022
Apr. 30 2022 0.25 0.26 0.27 Beat 3.8
Jan. 31 2022 0.21 0.22 0.20 Missed -7.8
Oct. 31 2021 0.35 0.35 0.35 Met 0.8
This summary was machine generated December 1 at 21:04 GMT. All
figures in US dollars unless otherwise stated